MyFinsight
Home
Blog
About
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
261.40%
Quick Ratio
261.40%
Cash Ratio
163.47%
Debt to Asset Ratio
68.67%
Unit: Thousand (K) dollars
Assets Breakdown
Operating lease right-of-use ass...
Cash and cash equivalents
Short-term investments
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Operating lease liabilities, net...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
12,860
11,703
17,753
9,601
Short-term investments
4,738
15,802
14,157
25,168
Restricted cash
200
200
784
784
Prepaid expenses and other current assets
2,766
2,555
2,912
2,783
Total current assets
20,564
30,260
35,606
38,336
Property and equipment, net
571
1,245
1,500
1,718
Operating lease right-of-use assets
17,075
19,230
19,881
20,517
Restricted cash, non-current
1,538
1,538
981
981
Long-term investments
509
4,337
6,906
13,725
Other assets
87
138
179
222
Total assets
40,344
56,748
65,053
75,499
Accounts payable
868
1,443
1,518
1,852
Accrued expenses and other current liabilities
3,089
3,717
3,839
5,387
Deferred revenue
819
449
1,909
2,512
Operating lease liabilities
3,091
2,826
2,700
2,559
Total current liabilities
7,867
8,435
9,966
12,310
Operating lease liabilities, net of current portion
18,533
20,132
20,889
21,624
Deferred revenue, non-current
1,172
1,544
1,964
2,590
Other long-term liabilities
132
132
133
133
Total liabilities
27,704
30,243
32,952
36,657
Additional paid-in capital
488,427
487,305
486,259
485,852
Accumulated other comprehensive loss
-44
-21
-10
-6
Accumulated deficit
-475,743
-460,779
-454,148
-447,004
Total stockholders' equity
12,640
26,505
32,101
38,842
Total liabilities and stockholders' equity
40,344
56,748
65,053
75,499
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$12,860K
(33.94%↑ Y/Y)
Short-term investments
$4,738K
(-81.17%↓ Y/Y)
Prepaid expenses and
other current assets
$2,766K
(-0.61%↓ Y/Y)
Restricted cash
$200K
(-74.49%↓ Y/Y)
Total current assets
$20,564K
(-46.36%↓ Y/Y)
Operating lease
right-of-use assets
$17,075K
(-16.78%↓ Y/Y)
Restricted cash,
non-current
$1,538K
(56.78%↑ Y/Y)
Property and equipment,
net
$571K
(-66.76%↓ Y/Y)
Long-term investments
$509K
(-96.29%↓ Y/Y)
Other assets
$87K
(-60.81%↓ Y/Y)
Total assets
$40,344K
(-46.56%↓ Y/Y)
Total liabilities and
stockholders' equity
$40,344K
(-46.56%↓ Y/Y)
Total liabilities
$27,704K
(-24.42%↓ Y/Y)
Total stockholders'
equity
$12,640K
(-67.46%↓ Y/Y)
Accumulated deficit
-$475,743K
(-6.43%↓ Y/Y)
Accumulated other
comprehensive loss
-$44K
(-633.33%↓ Y/Y)
Operating lease
liabilities, net of current...
$18,533K
(-14.29%↓ Y/Y)
Total current
liabilities
$7,867K
(-36.09%↓ Y/Y)
Deferred revenue,
non-current
$1,172K
(-54.75%↓ Y/Y)
Other long-term
liabilities
$132K
(-0.75%↓ Y/Y)
Additional paid-in capital
$488,427K
(0.53%↑ Y/Y)
Operating lease
liabilities
$3,091K
(20.79%↑ Y/Y)
Accrued expenses and
other current...
$3,089K
(-42.66%↓ Y/Y)
Accounts payable
$868K
(-53.13%↓ Y/Y)
Deferred revenue
$819K
(-67.40%↓ Y/Y)
Buy us a coffee